Design and synthesis of 4-[(s-triazin-2-ylamino)methyl]-N-(2-aminophenyl)-benzamides and their analogues as a novel class of histone deacetylase inhibitors-Reference-Cited by-同舟云学术

Design and synthesis of 4-[(s-triazin-2-ylamino)methyl]-N-(2-aminophenyl)-benzamides and their analogues as a novel class of histone deacetylase inhibitors

Published:2008-02 Issue:3 Volume:18 Page:1067-1071
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Paquin Isabelle,Raeppel Stéphane,Leit Silvana,Gaudette Frédéric,Zhou Nancy,Moradei Oscar,Saavedra Oscar,Bernstein Naomy,Raeppel Franck,Bouchain Giliane,Fréchette Sylvie,Woo Soon H.,Vaisburg Arkadii,Fournel Marielle,Kalita Ann,Robert Marie-France,Lu Aihua,Trachy-Bourget Marie-Claude,Yan Pu Theresa,Liu Jianhong,Rahil Jubrail,MacLeod A. Robert,Besterman Jeffrey M.,Li Zuomei,Delorme Daniel

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference23 articles.

1. Translating the Histone Code

2. Histone deacetylases and cancer: causes and therapies

3. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

4. Vorinostat

5. Garcia-Manero, G., et al. 42nd ASCO Annual Meeting, Atlanta, USA, 2006; Abstract 6500.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overview of class I HDAC modulators: Inhibitors and degraders;European Journal of Medicinal Chemistry;2024-10

2. Recent Progress in Histone Deacetylase (HDAC) 1 Inhibitors as Anticancer Agent;Current Cancer Drug Targets;2023-01

3. Discovery of Indole-Containing Benzamide Derivatives as HDAC1 Inhibitors with In Vitro and In Vivo Antitumor Activities;Pharmaceutical Fronts;2022-06

4. Heterocyclic Moieties as HDAC Inhibitors: Role in Cancer Therapeutic;Mini-Reviews in Medicinal Chemistry;2021-12-21

5. Discovery of quinazolinyl-containing benzamides derivatives as novel HDAC1 inhibitors with in vitro and in vivo antitumor activities;Bioorganic Chemistry;2021-12